SEVERE ACUTE KIDNEY INJURY IN HOSPITALIZED CANCER PATIENTS: PREDICTING RENAL REPLACEMENT THERAPY AND MORTALITY

https://storage.unitedwebnetwork.com/files/1099/572f71e0220729c423062aad408912f1.pdf
SEVERE ACUTE KIDNEY INJURY IN HOSPITALIZED CANCER PATIENTS: PREDICTING RENAL REPLACEMENT THERAPY AND MORTALITY
Gonçalo
Pimenta
Roberto Calças Marques roberto.calcas@gmail.com Centro Hospitalar Universitário do Algarve Nephrology Faro
Inês Sala inessala.db@gmail.com Centro Hospitalar Universitário de Santo António Nephrology Porto
Marina Reis marina.reis9@gmail.com Centro Hospitalar Universitário de Coimbra Nephrology Coimbra
Hugo Ferreira ferreihugo@gmail.com Instituto Português de Oncologia Nephrology Porto
Inês Coelho ines.coelho@ipoporto.min-saude.pt Instituto Português de Oncologia Nephrology Porto
Teresa Chuva m.teresa.chuva@gmail.com Instituto Português de Oncologia Nephrology Porto
Ana Paiva ana.paiva@ipoporto.min-saude.pt Instituto Português de Oncologia Nephrology Porto
José Maximino Costa jmaximinocosta@ipoporto.min-saude.pt Instituto Português de Oncologia Nephrology Porto
 
 
 
 
 
 
 

Acute kidney injury (AKI) is a common complication in cancer patients. This multifactorial condition often leads to longer hospital stay, discontinuation of cancer treatment, and poor prognosis. This study aimed to provide insight into the incidence of severe AKI in cancer patients and to identify the risk factors associated with renal replacement therapy (RRT) and mortality. 

This was a retrospective cohort study involving 3201 patients with cancer and severe AKI admitted to a Comprehensive Cancer Center between January 1995 and July 2023. Severe AKI was defined according to the KDIGO guidelines as grade ≥ 2 AKI with nephrological in-hospital follow-up. Patients without indications for cardiopulmonary resuscitation or those previously referred for palliative care were excluded. Data were collected from the electronic medical records and analyzed using SPSS® 26.0. 

To the best of our knowledge, this is one of the few studies addressing the demographic and clinical features of cancer patients with severe AKI. We created a prediction model for RRT and in-hospital mortality, and a risk score for hemato-oncological and all patients’ mortality. 

E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos